Connect with us

CAPILLARY

Capillary Technologies India Limited (capillary) Q1 Fy2027 Results: Revenue Up 43%, Adjusted Ebitda Surges 132%

Capillary Technologies India Limited (CAPILLARY) reports Q1 FY2027 results with 43% revenue growth and 132% Adjusted EBITDA increase.

adit chauhan author tradealone

Published

on

Capillary Technologies Capillary Q1 Fy2027 Results

Capillary Technologies India Limited (CAPILLARY) announced its financial results for the first quarter ended June 30, 2026. The company reported a strong quarter with a 43% year-on-year growth in operating revenue to 2,566.4 million compared to 1,798.9 million in the same quarter last year. Adjusted EBITDA also surged by 132% to 440.2 million from 189.7 million. Notably, normalized profit after tax (PAT) saw an exponential growth of 3,320% to 254.4 million.

Revenue and Profitability

The company’s operating revenue for Q1 FY2027 was 2,566.4 million, marking a significant 43% increase from 1,798.9 million in the previous year. The adjusted EBITDA for the quarter stood at 440.2 million, a remarkable 132% growth compared to 189.7 million in the same period last year. Despite the impressive revenue and profitability metrics, the company reported a negative PAT of 95.5 million, a stark contrast to the 7.4 million profit in the previous year.

Key Highlights

The robust performance was driven by healthy expansion within the existing customer base, growth in new annual contract value contributions, and the successful integration of SessionM, acquired in May 2026. Aneesh Reddy Boddu, Founder, MD & CEO, commented on the results, stating, “We delivered a strong quarter, driven by Net Retention Rate (NRR) expansion, the continued addition of large enterprise clients globally, and the successful closure of the SessionM acquisition from Mastercard.”

Source: NSE Corporate Announcement

Fundamental & Technical Analysis of Capillary Technologies India Limited

Capillary Technologies India Limited belongs to the sector. Here’s a quick read on where the business and the stock stand today.

CAPILLARY
Technology › Software - Application
APPROACHING SUPPORT
56
Fundamental
56
Technical
56
Overall

1W +4.78%
1M -7.9%
3M -2.26%
P/E: 91.5 Cap: Small
AI-Powered Analysis • TradeAlone
Download the App for in-depth analysis of this stock

Capillary falls 8.4% over three months and has not found a floor yet. Thin margins at 7.1% leave limited room for error — any demand softness or cost spike hits the bottom line hard. Revenue consistency is the one bright spot — zero dips in five years shows operational resilience. The stock sits at 9% of its 52-week range, close to annual lows. Historically, value investors build positions at these levels — though cheap stocks can stay cheap. Revenue grows at 42.2% and the stock moves sideways over three months. Neither side makes a strong case. The next earnings print will likely break this stock out of its current range. Check Fundamentals of Capillary Technologies India Limited.

CAPILLARY

Capillary Technologies India Limited (CAPILLARY) eases after clearing resistance, down 5% intraday

Capillary Technologies India Limited (NSE: CAPILLARY) shows pressure after breakout, moving down 5% intraday.

Pranab Tyagi at TradeAlone

Published

on

Capillary Technologies India Limited CAPILLARY pulls back from breakout highs

Capillary Technologies India Limited (CAPILLARY) pulls back from breakout highs, falling 5% to 530.4 on the NSE today. This retracement comes after the stock cleared a crucial 6-month resistance level at 512, marking a structural breakout. The pullback today is likely due to profit-taking following this breakout. Capillary Technologies operates in the technology sector, specifically in software infrastructure. Today’s move appears to be company-specific rather than a sector-wide trend, as it follows the breakout and subsequent profit-taking.

Technical setup — trendlines & DMA

The current 6-month trendline structure shows a breakout above the resistance level at 512, with the stock now trading 3.5% above this resistance. The 6-month support trendline is at 464.21, which is 12.48% below today’s price. The stock is currently trading 11% above the 50-day moving average (DMA) at 505.2, indicating an extended move. However, it is slightly below the 200-DMA at 560.7. The stock is in the lower third of its 52-week range, trading 20% above the 52-week low and 33.6% below the 52-week high, suggesting there is still room for further upside within the year.

6M Trendline — Intraday Snapshot
BREAKOUT₹475₹500₹525₹550₹57523 Mar12 May25 Jun10 Aug

Snapshot: 530.40 on 2026-08-10 (chart frozen at publication)

Fundamentals & business context

With a PE ratio of 81.7 and profit margins at 5.2%, Capillary Technologies is trading at a high valuation relative to its current earnings. The revenue CAGR of 34.0% indicates strong growth, but the thin profit margins suggest that the market may be pricing in future improvements or a potential turnaround. The 20.6% institutional ownership suggests that smart money has a moderate level of confidence in the company, though it is not overwhelmingly bullish. There is no NSE catalyst today, so the move is primarily technical.

CAPILLARY
Holdings Analysis
Key strengths & risk signals
56
Overall
56
Fundamental
57
Technical
Risks (4)
CAUTION! Company made loss in last quarter. Be careful.
POOR YEAR! Stock declined 25.5% in the last year.
WEAK POSITION! Current price (448.9) is below both moving averages.
WEAK! Trading at 3.0% of 52W range - near yearly lows.
Strengths (4)
Cannot calculate PEG - insufficient growth data.
BULLISH SENTIMENT! In last 30 days: 11 up days, 19 down days. Avg volume on up days: 1,658,626 vs down days: 470,913. Ratio: 3.52x
APPROACHING OVERSOLD! RSI at 33.7 - watch for reversal.
MARKET ALIGNED! Beta of 1.00 - moves with the market.

Algorithmic scorecard

The overall algorithmic scorecard reflects a technically strong but fundamentally weak position for Capillary Technologies. The strongest signals include the revenue and profit CAGRs, which are excellent at 34.0% and 27.0%, respectively, indicating robust growth. Additionally, the very low debt level with a D/E ratio of 0.00 points to excellent financial health. On the weaker side, the low profit margin of 5.2% leaves little room for error, and the PEG ratio of 3.03 suggests the stock is overvalued relative to its growth rate. The negligible dividend yield also means there is little to no income generation from this investment.

Fundamental & Technical AnalysisNSE: CAPILLARY
56Overall
56Fundamental
57Technical
Growth Quality17 / 30
Revenue CAGR: 42.2% (EXCELLENT, 15/15). Profit CAGR: 0% (DECLINING, 2/15).
Profit Margin3 / 10
LOW MARGIN! 5.2% profit margin - thin profits.
PEG Valuation7 / 10
Cannot calculate PEG - insufficient growth data.
Dividend Yield3 / 10
NEGLIGIBLE DIVIDEND! 0% yield - little to no income.
Debt / Equity10 / 10
VERY LOW DEBT! D/E of 0.00 - excellent financial health.
Public Holding14 / 20
MODERATE PUBLIC HOLDING! 26.03% public ownership - balanced ownership structure.
Stability2 / 10
CAUTION! Company made loss in last quarter. Be careful.
Moving Averages5 / 10
BEARISH TREND! 50-day average (502.1) is below 200-day average (545.6) - negative signal.
Price Position2 / 10
WEAK POSITION! Current price (484.1) is below both moving averages.
Trend Pattern10 / 20
TESTING SUPPORT! Stock is at key support level.
52W Performance1 / 10
POOR YEAR! Stock declined 25.5% in the last year.
Volume Sentiment30 / 30
BULLISH SENTIMENT! In last 30 days: 12 up days, 18 down days. Avg volume on up days: 1,564,770 vs down days: 484,444. Ratio: 3.23x
RSI3 / 5
NEUTRAL! RSI at 49.0 - balanced momentum.
52W Range1 / 5
WEAK! Trading at 12.7% of 52W range - near yearly lows.
Momentum2 / 5
WEAK MOMENTUM! Limited price growth - 4.8% (1 week), -7.9% (1 month), -2.3% (3 months).
Beta / Volatility3 / 5
MARKET ALIGNED! Beta of 1.00 - moves with the market.

Company outlook

Management expects EBITDA margins to remain sustainable, with a potential dip due to the SessionM acquisition. The core organic business is projected to reach a steady-state EBITDA margin of 25-30%. Revenues are anticipated to exceed INR 1,000-1,050 crores in FY27, driven by both the SessionM acquisition and organic growth. SessionM is expected to significantly contribute to revenue growth and EBITDA in the coming years. The company plans to maintain a 115% NRR on the organic business and target upgrades on the inorganic side to improve margins. An AI-led platform is in development to upgrade customers from acquired stacks to Capillary, aiming to accelerate margin improvements and integrations.

Get all details on CAPILLARY — P&L, peers, shareholding and more on TradeAlone.

Continue Reading

CAPILLARY

Capillary Technologies India Limited (CAPILLARY) gains 10% intraday, breaks out

Capillary Technologies India Limited (CAPILLARY) stock gains 10% intraday, breaking out from its 6M resistance trendline.

Pranab Tyagi at TradeAlone

Published

on

Capillary Technologies India Limited CAPILLARY breaks out

Capillary Technologies India Limited (CAPILLARY) breaks out, gaining +10% to 589.4 on the NSE on 05 Aug 2026, backed by its Q1 FY2027 results showing a 43% revenue increase and a 132% surge in adjusted EBITDA. This move is company-specific, driven by strong financial performance rather than sector-wide momentum. Capillary Technologies, a player in the technology sector focusing on software infrastructure, has shown remarkable growth, distinguishing itself from broader market trends.

Technical setup — trendlines & DMA

From a technical standpoint, CAPILLARY has cleared its 6-month resistance trendline, currently standing at 511.86, marking a breakout. The stock is now trading 13.16% above this resistance level, indicating strong upward momentum. The 6-month support trendline is at 466.56, which is 20.84% below the current price, providing a solid floor. The 50-day moving average (DMA) at 504.1 is below the 200-DMA at 561.1, suggesting a bearish trend in the short term but a bullish trend in the long term. CAPILLARY is currently in the middle third of its 52-week range, which spans from 464.2 to 799.0, implying there is room for further upside.

6M Trendline — Intraday Snapshot
BREAKOUT₹475₹500₹525₹550₹57523 Mar11 May23 Jun5 Aug

Snapshot: 589.40 on 2026-08-05 (chart frozen at publication)

Fundamentals & business context

Fundamentally, CAPILLARY presents a mixed picture. With a PE ratio of 78.0 and profit margins at 7.1%, the valuation appears stretched relative to current earnings, especially given the thin profit margins. However, the revenue CAGR of 42.2% over the past five years indicates strong growth potential. Institutional ownership stands at 20.6%, suggesting that smart money has a moderate level of confidence in the company. The recent NSE filing highlights a robust quarter with significant revenue and EBITDA growth, reinforcing the positive sentiment around the stock.

CAPILLARY
Holdings Analysis
Key strengths & risk signals
56
Overall
56
Fundamental
57
Technical
Risks (4)
CAUTION! Company made loss in last quarter. Be careful.
POOR YEAR! Stock declined 25.5% in the last year.
WEAK POSITION! Current price (448.9) is below both moving averages.
WEAK! Trading at 3.0% of 52W range - near yearly lows.
Strengths (4)
Cannot calculate PEG - insufficient growth data.
BULLISH SENTIMENT! In last 30 days: 11 up days, 19 down days. Avg volume on up days: 1,658,626 vs down days: 470,913. Ratio: 3.52x
APPROACHING OVERSOLD! RSI at 33.7 - watch for reversal.
MARKET ALIGNED! Beta of 1.00 - moves with the market.

Algorithmic scorecard

The algorithmic scorecard reflects a technically strong but fundamentally weaker profile for CAPILLARY. The breakout above resistance and the bullish sentiment over the last 30 days, with an 8.57x higher average volume on up days compared to down days, signal strong accumulation and positive market sentiment. However, the low profit margin of 7.1% and the negligible dividend yield of 0% represent significant risks. The company’s excellent revenue growth consistency and very low debt level are strong positives, but the declining profit CAGR and lack of dividend income could be concerns for income-focused investors.

Fundamental & Technical AnalysisNSE: CAPILLARY
56Overall
56Fundamental
57Technical
Growth Quality17 / 30
Revenue CAGR: 42.2% (EXCELLENT, 15/15). Profit CAGR: 0% (DECLINING, 2/15).
Profit Margin3 / 10
LOW MARGIN! 5.2% profit margin - thin profits.
PEG Valuation7 / 10
Cannot calculate PEG - insufficient growth data.
Dividend Yield3 / 10
NEGLIGIBLE DIVIDEND! 0% yield - little to no income.
Debt / Equity10 / 10
VERY LOW DEBT! D/E of 0.00 - excellent financial health.
Public Holding14 / 20
MODERATE PUBLIC HOLDING! 26.03% public ownership - balanced ownership structure.
Stability2 / 10
CAUTION! Company made loss in last quarter. Be careful.
Moving Averages5 / 10
BEARISH TREND! 50-day average (502.1) is below 200-day average (545.6) - negative signal.
Price Position2 / 10
WEAK POSITION! Current price (484.1) is below both moving averages.
Trend Pattern10 / 20
TESTING SUPPORT! Stock is at key support level.
52W Performance1 / 10
POOR YEAR! Stock declined 25.5% in the last year.
Volume Sentiment30 / 30
BULLISH SENTIMENT! In last 30 days: 12 up days, 18 down days. Avg volume on up days: 1,564,770 vs down days: 484,444. Ratio: 3.23x
RSI3 / 5
NEUTRAL! RSI at 49.0 - balanced momentum.
52W Range1 / 5
WEAK! Trading at 12.7% of 52W range - near yearly lows.
Momentum2 / 5
WEAK MOMENTUM! Limited price growth - 4.8% (1 week), -7.9% (1 month), -2.3% (3 months).
Beta / Volatility3 / 5
MARKET ALIGNED! Beta of 1.00 - moves with the market.

Company outlook

Management’s forward guidance for Capillary Technologies is optimistic, with expectations for EBITDA margins to remain sustainable, despite a potential dip due to the SessionM acquisition. The company anticipates core organic business margins to reach a steady-state of 25-30% EBITDA margin. Revenues are projected to exceed INR 1,000-1,050 crores in FY27, driven by both organic growth and the SessionM acquisition. SessionM is expected to significantly contribute to revenue and EBITDA in the coming years. The company plans to maintain a 115% NRR on the organic business and target upgrades on the inorganic side to enhance margins. An AI-led platform is in development to upgrade customers from acquired stacks to Capillary, aiming to accelerate margin improvements and integrations.

Get all details on CAPILLARY — P&L, peers, shareholding and more on TradeAlone.

Continue Reading

CAPILLARY

Capillary Technologies India Limited (CAPILLARY) breaks out, gains 7% intraday

Capillary Technologies India Limited (NSE: CAPILLARY) stock breaks out, gaining 7% intraday to 572.7, backed by strong Q1 FY2027 results.

seema chauhan author

Published

on

Capillary Technologies India Limited CAPILLARY breakout

Capillary Technologies India Limited (CAPILLARY) breaks out, gaining +7% to 572.7 on the NSE on 05 Aug 2026, backed by its Q1 FY2027 results showing a 43% revenue increase. This move is driven by the company’s strong financial performance, which has cleared its 6-month resistance trendline after a period of consolidation. Capillary Technologies, a player in the technology sector specializing in software infrastructure, has shown a company-specific surge rather than aligning with broader sector momentum.

Technical setup — trendlines & DMA

The current 6-month trendline structure shows a breakout above the resistance level of 511.86, with the stock now trading 10.62% above this point. The 6-month support floor is at 466.56, which is 18.53% below today’s price, indicating a strong upward move. The 50-day moving average (DMA) is at 504.1, while the 200-DMA is at 561.1, showing that the stock is trading above the 50-DMA but still below the 200-DMA. This suggests a mixed position in terms of moving averages. The stock is currently in the lower third of its 52-week range, indicating that there may be room for further upside as it has only recovered 32% from its 52-week low.

6M Trendline — Intraday Snapshot
BREAKOUT₹475₹500₹525₹550₹57523 Mar11 May23 Jun5 Aug

Snapshot: 572.70 on 2026-08-05 (chart frozen at publication)

Fundamentals & business context

With a PE ratio of 78.0, Capillary Technologies is trading at a high valuation relative to its profit margin of 7.1%, which suggests that the market may be pricing in future growth rather than current earnings. The company’s revenue CAGR of 42.2% over the past five years indicates strong growth, but the absence of profit CAGR suggests that this growth has not yet translated into consistent profitability. The 20.6% institutional ownership reflects a cautious yet interested stance from the smart money, possibly indicating a balance between growth potential and risk. Today’s move is directly linked to the strong Q1 FY2027 results, which served as a clear catalyst.

CAPILLARY
Holdings Analysis
Key strengths & risk signals
56
Overall
56
Fundamental
57
Technical
Risks (4)
CAUTION! Company made loss in last quarter. Be careful.
POOR YEAR! Stock declined 25.5% in the last year.
WEAK POSITION! Current price (448.9) is below both moving averages.
WEAK! Trading at 3.0% of 52W range - near yearly lows.
Strengths (4)
Cannot calculate PEG - insufficient growth data.
BULLISH SENTIMENT! In last 30 days: 11 up days, 19 down days. Avg volume on up days: 1,658,626 vs down days: 470,913. Ratio: 3.52x
APPROACHING OVERSOLD! RSI at 33.7 - watch for reversal.
MARKET ALIGNED! Beta of 1.00 - moves with the market.

Algorithmic scorecard

The overall algorithmic scorecard reflects a technically strong but fundamentally weaker profile for Capillary Technologies. The strongest signals come from the breakout above resistance levels with momentum, indicating a positive technical setup, and the consistent revenue growth every year, which points to exceptional business stability. On the weaker side, the low profit margin of 7.1% leaves little room for error, and the negligible dividend yield offers little to no income for investors. These factors highlight the risk of thin profits and the lack of income generation through dividends.

Fundamental & Technical AnalysisNSE: CAPILLARY
56Overall
56Fundamental
57Technical
Growth Quality17 / 30
Revenue CAGR: 42.2% (EXCELLENT, 15/15). Profit CAGR: 0% (DECLINING, 2/15).
Profit Margin3 / 10
LOW MARGIN! 5.2% profit margin - thin profits.
PEG Valuation7 / 10
Cannot calculate PEG - insufficient growth data.
Dividend Yield3 / 10
NEGLIGIBLE DIVIDEND! 0% yield - little to no income.
Debt / Equity10 / 10
VERY LOW DEBT! D/E of 0.00 - excellent financial health.
Public Holding14 / 20
MODERATE PUBLIC HOLDING! 26.03% public ownership - balanced ownership structure.
Stability2 / 10
CAUTION! Company made loss in last quarter. Be careful.
Moving Averages5 / 10
BEARISH TREND! 50-day average (502.1) is below 200-day average (545.6) - negative signal.
Price Position2 / 10
WEAK POSITION! Current price (484.1) is below both moving averages.
Trend Pattern10 / 20
TESTING SUPPORT! Stock is at key support level.
52W Performance1 / 10
POOR YEAR! Stock declined 25.5% in the last year.
Volume Sentiment30 / 30
BULLISH SENTIMENT! In last 30 days: 12 up days, 18 down days. Avg volume on up days: 1,564,770 vs down days: 484,444. Ratio: 3.23x
RSI3 / 5
NEUTRAL! RSI at 49.0 - balanced momentum.
52W Range1 / 5
WEAK! Trading at 12.7% of 52W range - near yearly lows.
Momentum2 / 5
WEAK MOMENTUM! Limited price growth - 4.8% (1 week), -7.9% (1 month), -2.3% (3 months).
Beta / Volatility3 / 5
MARKET ALIGNED! Beta of 1.00 - moves with the market.

Company outlook

Capillary Technologies has provided forward guidance indicating that revenues are expected to cross INR 1,000-1,050 crores in FY27, driven by the SessionM acquisition and organic growth. The company expects EBITDA margins to remain at sustainable levels, with a core organic business moving towards a steady-state EBITDA margin of 25-30%. SessionM is expected to deliver significant revenue growth and EBITDA contributions in the coming years. The company plans to maintain a focus on a 115% NRR on the organic business and target upgrades on the inorganic side to improve margins. Additionally, Capillary Technologies intends to develop an AI-led platform to upgrade customers from acquired stacks to Capillary, aiming to accelerate margin improvements and integrations.

Get all details on CAPILLARY — P&L, peers, shareholding and more on TradeAlone.

Continue Reading

Trending